Internalizing antibody-based targeted gene delivery for human cancer cells

Human Gene Therapy

Volumn 18, Issue 11, 2007, Pages 1153-1160

  Shiota, Maki ^a,b   Ikeda, Yutaka ^a   Kaul, Zeenia ^a   Itadani, Jun ^a   Kaul, Sunil C ^a   Wadhwa, Renu ^a,b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHAPERONE; HEAT SHOCK PROTEIN 70; MONOCLONAL ANTIBODY; MORTALIN; NANOCARRIER; NANOPARTICLE; POLYCLONAL ANTIBODY; POLYETHYLENEIMINE; POLYMER; QUANTUM DOT; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER CELL; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE TARGETING; GENE THERAPY; GENE VECTOR; GLIOBLASTOMA; HUMAN; HUMAN CELL; ILLUMINATION; INTERNALIZATION; LIVER CELL CARCINOMA; LUNG CARCINOMA; NONVIRAL GENE DELIVERY SYSTEM; OSTEOSARCOMA; UROGENITAL TRACT CANCER; UTERINE CERVIX CARCINOMA;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; FIBROBLASTS; GENE TARGETING; GENE TRANSFER TECHNIQUES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; POLYETHYLENEIMINE;

EID: 36148965562     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.087     Document Type: Article

References (35)

1. AOKI, K., FURUHATA, S., HATANAKA, K., MAEDA, M., REMY, J.S., BEHR, J.P., TERADA, M., and YOSHIDA, T. (2001). Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Ther. 8, 508-514.
2. BOUSSIF, O., LEZOUALC'H, F., ZANTA, M.A., MERGNY, M.D., SCHERMAN, D., DEMENEIX, B., and BEHR, J.P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92, 7297-7301.
3. CHIU, S.J., UENO, N.T., and LEE, R.J. (2004). Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J. Control. Release 97, 357-369.
4. CUSSAC, D., PICHEREAUX, C., COLOMBA, A., CAPILLA, F., PONT, F., GAITS-IACOVONI, F., LAMANT, L., ESPINOS, E., BURLET-SCHILTZ, O., MONSARRAT, B., DELSOL, G., and PAYRASTRE, B. (2006). Proteomic analysis of anaplastic lymphoma cell lines: Identification of potential tumour markers. Proteomics 6, 3210-3222.
5. DENSMORE, C.L., KLEINERMAN, E.S., GAUTAM, A., JIA, S.F., XU, B., WORTH, L.L., WALDREP, J.C., FUNG, Y.K., T'ANG, A., and KNIGHT, V. (2001). Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes. Cancer Gene Ther. 8, 619-627.
6. DEOCARIS, C.C., WIDODO, N., SHRESTHA, B.G., KAUR, K., OHTAKA, M., YAMASAKI, K., KAUL, S.C., and WADHWA, R. (2007). Mortalin sensitizes human cancer cells to MKT-077-induced senescence. Cancer Lett. 252, 259-269.
7. DUNDAS, S.R., LAWRIE, L.C., ROONEY, P.H., and MURRAY, G.I. (2004). Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J. Pathol. 205, 74-81.
8. GAUTAM, A., DENSMORE, C.L., and WALDREP, J.C. (2000). Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes. Mol. Ther. 2, 318-323.
9. GUILLEM, V.M., TORMO, M., REVERT, F., BENET, I., GARCIACONDE, J., CRESPO, A., and ALINO, S.F. (2002). Polyethyleneimine-based immunopolyplex for targeted gene transfer in human lymphoma cell lines. J. Gene Med. 4, 170-182.
10. GUO, W., and LEE, R.L. (1999). Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS PharmSci. 1, E19.
11. HATTORI, Y., KAWAKAMI, S., SUZUKI, S., YAMASHITA, F., and HASHIDA, M. (2004). Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun. 317, 992-999.
12. HU-LIESKOVAN, S., HEIDEL, J.D., BARTLETT, D.W., DAVIS, M.E., and TRICHE, T.J. (2005). Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65, 8984-8992.
13. KAUL, S.C., AIDA, S., YAGUCHI, T., KAUR, K., and WADHWA, R. (2005). Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides. J. Biol. Chem. 280, 39373-39379.
14. KAUL, S.C., DEOCARIS, C.C., and WADHWA, R. (2007). Three faces of mortalin: A housekeeper, guardian and killer. Exp. Gerontol. 42, 263-274.
15. KAUL, Z., YAGUCHI, T., HARADA, J.I., IKEDA, Y., HIRANO, T., CHIURA, H.X., KAUL, S.C., and WADHWA R. (2007a). An antibody-conjugated internalizing quantum dot suitable for long-term live imaging of cells. Biochem. Cell Biol. 85, 133-140.
16. KIM, S.H., JEONG, J.H., CHO, K.C., KIM, S.W., and PARK, T.G. (2005). Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J. Control. Release 104, 223-232.
17. KUNATH, K., MERDAN, T., HEGENER, O., HABERLEIN, H., and KISSEL, T. (2003). Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J. Gene Med. 5, 588-599.
18. LEMKINE, G.F., and DEMENEIX, B.A. (2001). Polyethylenimines for in vivo gene delivery. Curr. Opin. Mol. Ther. 3, 178-182.
19. MA, Z., IZUMI, H., KANAI, M., KABUYAMA, Y., AHN, N.G., and FUKASAWA, K. (2006). Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene 25, 5377-5390.
20. MERDAN, T., CALLAHAN, J., PETERSEN, H., KUNATH, K., BAKOWSKY, U., KOPECKOVA, P., KISSEL, T., and KOPECEK, J. (2003). Pegylated polyethylenimine-Fab′ antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug. Chem. 14, 989-996.
21. MERLIN, J.L., N'DOYE, A., BOURIEZ, T., and DOLIVET, G. (2002). Polyethylenimine derivatives as potent nonviral vectors for gene transfer. Drug News Perspect. 15, 445-451.
22. MOFFATT, S., and CRISTIANO, R.J. (2006). PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: In vitro evaluation in human prostate cancer cells. Int. J. Pharm. 317, 10-13.
23. NAKABAYASHI, K., OGATA, T., FUJII, M., TAHARA, H., IDE, T., WADHWA, R., KAUL, S.C., MITSUI, Y., and AYUSAWA, D. (1997). Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp. Cell Res. 235, 345-353.
24. SHIN, B.K., WANG, H., YIM, A.M., LE NAOUR, F., BRICHORY, F., JANG, J.H., ZHAO, R., PURAVS, E., TRA, J., MICHAEL, C.W., MISEK, D., and HANASH, S. (2003). Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 278, 7607-7616.
25. STREHBLOW, C., SCHUSTER, M., MORITZ, T., KIRCH, H.C., OPALKA, B., and PETRI, J.B. (2005). Monoclonal antibody-polyethyleneimine conjugates targeting Her-2/neu or CD90 allow cell type-specific nonviral gene delivery. J. Control. Release 102, 737-747.
26. WADHWA, R., KAUL, S.C., MITSUI, Y., and SUGIMOTO, Y. (1993). Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts. Exp. Cell Res. 207, 442-448.
27. WADHWA, R., PEREIRA-SMITH, O.M., REDDEL, R.R., SUGIMOTO, Y., MITSUI, Y., and KAUL, S.C. (1995). Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp. Cell Res. 216, 101-106.
28. WADHWA, R., SUGIHARA, T., YOSHIDA, A., NOMURA, H., REDDEL, R.R., SIMPSON, R., MARUTA, H., and KAUL, S.C. (2000). Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the Hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res. 60, 6818-6821.
29. WADHWA, R., ANDO, H., KAWASAKI, H., TAIRA, K., and KAUL, S.C. (2003). Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes. EMBO Rep. 4, 595-601.
30. WADHWA, R., TAKANO, S., KAUR, K., AIDA, S., YAGUCHI, T., KAUL, Z., HIRANO, T., TAIRA, K., and KAUL, S.C. (2005). Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60. Biochem. J. 391, 185-190.
31. WADHWA, R., TAKANO, S., KAUR, K., DEOCARIS, C.C., PEREIRA-SMITH, O.M., REDDEL, R.R., and KAUL, S.C. (2006). Upregulation of mortalin/mtHSP70/Grp75 contributes to human carcinogenesis. Int. J. Cancer 118, 2973-2980.
32. WERTH, S., URBAN-KLEIN, B., DAI, L., HOBEL, S., GRZELINSKI, M., BAKOWSKY, U., CZUBAYKO, F., and AIGNER, A. (2006). A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J. Control. Release 112, 257-270.
33. WIDODO, N., DEOCARIS, C.C., KAUR, K., HASAN, K., YAGUCHI, T., YAMASAKI, K., SUGIHARA, T., ISHII, T., WADHWA, R., and KAUL, S.C. (2007). Stress chaperones, mortalin, and pex19p mediate 5-aza-2′ deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway. J. Gerontol. A Biol. Sci. Med. Sci. 62, 246-255.
34. XU, D.M., YAO, S.D., LIU, Y.B., SHENG, K.L., HONG, J., GONG, P.J., and DONG, L. (2007). Size-dependent properties of M-PEIs nanogels for gene delivery in cancer cells. Int. J. Pharm. 338, 291-296.
35. ZANTA, M.A., BOUSSIF, O., ADIB, A., and BEHR, J.P. (1997). In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug. Chem. 8, 839-844.